Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × pegaspargase × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 37 Leukemia 16 Lymphoma 7 Burkitt Lymphoma 6 Recurrence 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5 Leukemia, Biphenotypic, Acute 3 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Leukemia, T-Cell 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia, B-Cell 1 Immunoproliferative Disorders 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 Drug-Related Side Effects and Adverse Reactions 1 Blast Crisis 1

Interventions

Cyclophosphamide 31 fludarabine 23 fludarabine phosphate 22 Tacrolimus 22 Whole-Body Irradiation 21 Mycophenolic Acid 19 Busulfan 14 Melphalan 11 thymoglobulin 10 Methotrexate 10 Granulocyte Colony-Stimulating Factor 10 Antilymphocyte Serum 10 Stem Cell Transplantation 9 Rituximab 9 Filgrastim 8 Thiotepa 7 Cyclosporine 7 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Cytarabine 6 Nivolumab 5 Bortezomib 5 Alemtuzumab 5 trametinib 4 Sirolimus 4 Hematopoietic Stem Cell Transplantation 4 Dexamethasone 4 Cyclosporins 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡